(ABVE) Above Food Ingredients - Ratings and Ratios
Regenerative Grains, Bespoke Ingredients, Consumer Products, Private Label
Dividends
Currently no dividends paid| Risk via 10d forecast | |
|---|---|
| Volatility | 293% |
| Value at Risk 5%th | 395% |
| Relative Tail Risk | -17.99% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 1.42 |
| Alpha | 266.14 |
| CAGR/Max DD | -0.42 |
| Character TTM | |
|---|---|
| Hurst Exponent | 0.527 |
| Beta | 1.897 |
| Beta Downside | 1.355 |
| Drawdowns 3y | |
|---|---|
| Max DD | 97.50% |
| Mean DD | 45.23% |
| Median DD | 24.83% |
Description: ABVE Above Food Ingredients October 28, 2025
Above Food Ingredients Inc. (NASDAQ: ABVE) is a regenerative-focused ingredient producer headquartered in Regina, Canada. The firm operates a vertically integrated supply chain across North America, Europe, and Asia, and is organized into two segments: (1) Disruptive Agriculture & Rudimentary Ingredients, which handles the genetics, sourcing, grading, processing, and sale of regeneratively grown grains and bespoke ingredient products; and (2) Consumer Packaged Goods, which develops, manufactures, and markets both owned-brand and private-label food products.
Key performance indicators that investors typically monitor for ABVE include: (i) grain-sourcing volume (measured in metric tons) and the proportion sourced under regenerative practices, (ii) gross margin trends in the CPG segment (historically ranging 30-40% but sensitive to commodity price volatility), and (iii) revenue growth from private-label contracts, which has been a primary driver of recent top-line expansion. The sector is heavily influenced by macro-drivers such as global grain price cycles, increasing consumer demand for sustainably sourced food, and regulatory incentives for regenerative agriculture in Canada and the EU.
For a deeper, data-rich analysis of ABVE’s valuation metrics and scenario modeling, you may find the research tools on ValueRay worth exploring.
Piotroski VR‑10 (Strict, 0-10) 1.0
| Net Income (-1.66m TTM) > 0 and > 6% of Revenue (6% = 13.1m TTM) |
| FCFTA -0.02 (>2.0%) and ΔFCFTA 0.44pp (YES ≥ +1.0pp, WARN ≥ +0.5pp) |
| NWC/Revenue -58.49% (prev -1.00%; Δ -57.50pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp) |
| CFO/TA -0.02 (>3.0%) and CFO -2.21m <= Net Income -1.66m (YES >=105%, WARN >=100%) |
| NO Net Debt/EBITDA fails (EBITDA <= 0) |
| Current Ratio 0.23 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active) |
| Outstanding Shares last Quarter (28.5m) change vs 12m ago 229.9% (target <= -2.0% for YES) |
| Gross Margin -1.94% (prev 99.73%; Δ -101.7pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0) |
| Asset Turnover 284.4% (prev 961.9%; Δ -677.5pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0) |
| Interest Coverage Ratio -6.43 (EBITDA TTM -4.26m / Interest Expense TTM 4.05m) >= 6 (WARN >= 3) |
Altman Z'' -14.46
| (A) -1.14 = (Total Current Assets 38.6m - Total Current Liabilities 166.4m) / Total Assets 112.4m |
| (B) -1.25 = Retained Earnings (Balance) -140.3m / Total Assets 112.4m |
| warn (B) unusual magnitude: -1.25 — check mapping/units |
| (C) -0.34 = EBIT TTM -26.1m / Avg Total Assets 76.8m |
| (D) -0.62 = Book Value of Equity -140.3m / Total Liabilities 227.6m |
| Total Rating: -14.46 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D) |
ValueRay F-Score (Strict, 0-100) 44.09
| 1. Piotroski 1.0pt |
| 2. FCF Yield -0.71% |
| 3. FCF Margin -1.01% |
| 4. Debt/Equity -1.02 |
| 5. Debt/Ebitda -22.54 |
| 6. ROIC - WACC (= 39.53)% |
| 7. RoE 7.91% |
| 8. Rev. Trend -100.0% |
| 9. EPS Trend -36.69% |
What is the price of ABVE shares?
Over the past week, the price has changed by -25.00%, over one month by -21.89%, over three months by +26.22% and over the past year by +324.18%.
Is ABVE a buy, sell or hold?
What are the forecasts/targets for the ABVE price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | - | - |
| Analysts Target Price | - | - |
| ValueRay Target Price | 2 | -3.9% |
ABVE Fundamental Data Overview December 03, 2025
P/S = 0.4809
Beta = -0.127
Revenue TTM = 218.4m CAD
EBIT TTM = -26.1m CAD
EBITDA TTM = -4.26m CAD
Long Term Debt = 25.7m CAD (from longTermDebt, last quarter)
Short Term Debt = 71.1m CAD (from shortLongTermDebt, last quarter)
Debt = 117.5m CAD (from shortLongTermDebtTotal, last fiscal year)
Net Debt = 96.1m CAD (from netDebt column, last quarter)
Enterprise Value = 312.1m CAD (195.2m + Debt 117.5m - CCE 664.4k)
Interest Coverage Ratio = -6.43 (Ebit TTM -26.1m / Interest Expense TTM 4.05m)
FCF Yield = -0.71% (FCF TTM -2.21m / Enterprise Value 312.1m)
FCF Margin = -1.01% (FCF TTM -2.21m / Revenue TTM 218.4m)
Net Margin = -0.76% (Net Income TTM -1.66m / Revenue TTM 218.4m)
Gross Margin = -1.94% ((Revenue TTM 218.4m - Cost of Revenue TTM 222.6m) / Revenue TTM)
Gross Margin QoQ = -4.52% (prev none%)
Tobins Q-Ratio = 2.78 (Enterprise Value 312.1m / Total Assets 112.4m)
Interest Expense / Debt = 1.88% (Interest Expense 2.21m / Debt 117.5m)
Taxrate = 120.8% (out of range, set to none) (189.4k / 156.8k)
NOPAT = unknown (EBIT/Op.Income or Taxrate missing)
Current Ratio = 0.23 (Total Current Assets 38.6m / Total Current Liabilities 166.4m)
Debt / Equity = -1.02 (negative equity) (Debt 117.5m / totalStockholderEquity, last quarter -115.2m)
Debt / EBITDA = -22.54 (negative EBITDA) (Net Debt 96.1m / EBITDA -4.26m)
Debt / FCF = -43.47 (negative FCF - burning cash) (Net Debt 96.1m / FCF TTM -2.21m)
Total Stockholder Equity = -21.0m (last 4 quarters mean from totalStockholderEquity)
RoA = -1.48% (Net Income -1.66m / Total Assets 112.4m)
RoE = 7.91% (negative equity) (Net Income TTM -1.66m / Total Stockholder Equity -21.0m)
RoCE = -559.6% (out of range, set to none) (EBIT -26.1m / Capital Employed (Equity -21.0m + L.T.Debt 25.7m))
RoIC = 47.65% (negative operating profit) (EBIT -26.1m / (Assets 112.4m - Curr.Liab 166.4m - Cash 664.4k))
WACC = 8.12% (E(195.2m)/V(312.8m) * Re(13.01%) + (debt cost/tax rate unavailable))
Discount Rate = 13.01% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 100.0 | Cagr: 117.9%
Fair Price DCF = unknown (Cash Flow -2.21m)
EPS Correlation: -36.69 | EPS CAGR: -2.10% | SUE: N/A | # QB: 0
Revenue Correlation: -100.0 | Revenue CAGR: -65.61% | SUE: N/A | # QB: 0
Additional Sources for ABVE Stock
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle